Zobrazeno 1 - 10
of 357
pro vyhledávání: '"S. Alva"'
Autor:
Charles B. Nguyen, Ajjai S. Alva
Publikováno v:
Advances in Oncology. 3:129-136
Autor:
Arul M. Chinnaiyan, A. Robert MacLeod, Youngsoo Kim, Ajjai S. Alva, Xuhong Cao, Alice Xu, Kristin M. Juckette, Andrew Delekta, Esther Luo, Xiaojun Jing, Fengyun Su, Heng Zheng, Xiaoju Wang, Sudhanshu Shukla, Yuanyuan Qiao, Lisha Wang, Yajia Zhang, Abhijit Parolia, Mengyao Tan, Josh Vo, Jean C. Tien, Lanbo Xiao
Supplementary Table 1: List of the compounds in the epigenetic inhibitor library.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0056b26f4599a31c81525a93542a9cb
https://doi.org/10.1158/0008-5472.22419987.v1
https://doi.org/10.1158/0008-5472.22419987.v1
Autor:
Arul M. Chinnaiyan, A. Robert MacLeod, Youngsoo Kim, Ajjai S. Alva, Xuhong Cao, Alice Xu, Kristin M. Juckette, Andrew Delekta, Esther Luo, Xiaojun Jing, Fengyun Su, Heng Zheng, Xiaoju Wang, Sudhanshu Shukla, Yuanyuan Qiao, Lisha Wang, Yajia Zhang, Abhijit Parolia, Mengyao Tan, Josh Vo, Jean C. Tien, Lanbo Xiao
This file includes Supplementary Figures S1-S8. Figure S1: Inhibition of EPZ6438 and ASO-EZH2 sensitizes enzalutamide-resistant LNCaP cells to enzalutamide or ASO-AR. Figure S2: Design and validation of sgRNA targeting EZH2. Figure S3: Growth inhibit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b74e293913dbca7b62487c878666eba
https://doi.org/10.1158/0008-5472.22419990.v1
https://doi.org/10.1158/0008-5472.22419990.v1
Autor:
Arul M. Chinnaiyan, A. Robert MacLeod, Youngsoo Kim, Ajjai S. Alva, Xuhong Cao, Alice Xu, Kristin M. Juckette, Andrew Delekta, Esther Luo, Xiaojun Jing, Fengyun Su, Heng Zheng, Xiaoju Wang, Sudhanshu Shukla, Yuanyuan Qiao, Lisha Wang, Yajia Zhang, Abhijit Parolia, Mengyao Tan, Josh Vo, Jean C. Tien, Lanbo Xiao
Supplementary information with additional materials and methods, references, and the legends for all supplementary figures.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ae87a07609a8acae31b96f5c8d4555b
https://doi.org/10.1158/0008-5472.22419996.v1
https://doi.org/10.1158/0008-5472.22419996.v1
Autor:
Arul M. Chinnaiyan, A. Robert MacLeod, Youngsoo Kim, Ajjai S. Alva, Xuhong Cao, Alice Xu, Kristin M. Juckette, Andrew Delekta, Esther Luo, Xiaojun Jing, Fengyun Su, Heng Zheng, Xiaoju Wang, Sudhanshu Shukla, Yuanyuan Qiao, Lisha Wang, Yajia Zhang, Abhijit Parolia, Mengyao Tan, Josh Vo, Jean C. Tien, Lanbo Xiao
Advanced prostate cancer initially responds to androgen deprivation therapy (ADT), but the disease inevitably recurs as castration-resistant prostate cancer (CRPC). Although CRPC initially responds to abiraterone and enzalutamide, the disease invaria
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9f2c3a2f68aa78b18e9a1b8942680041
https://doi.org/10.1158/0008-5472.c.6510525.v1
https://doi.org/10.1158/0008-5472.c.6510525.v1
Autor:
Scott A. Tomlins, Daniel R. Rhodes, Kathleen R. Cho, Paul D. Williams, Santhoshi Bandla, Seth Sadis, Javed Siddiqui, Jeffrey S. Montgomery, Todd M. Morgan, Ajjai S. Alva, Felix Y. Feng, Rohit Mehra, Alon Z. Weizer, Yajia Zhang, Yali Zhai, Chia-Jen Liu, Andi K. Cani, Daniel H. Hovelson, Andrew S. McDaniel
Description of additional methods and procedures used in the study. Also includes Supplementary References.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0861852fd29d4af3a48d0bb7cdd01393
https://doi.org/10.1158/0008-5472.22406991.v1
https://doi.org/10.1158/0008-5472.22406991.v1
Autor:
Scott A. Tomlins, Daniel R. Rhodes, Kathleen R. Cho, Paul D. Williams, Santhoshi Bandla, Seth Sadis, Javed Siddiqui, Jeffrey S. Montgomery, Todd M. Morgan, Ajjai S. Alva, Felix Y. Feng, Rohit Mehra, Alon Z. Weizer, Yajia Zhang, Yali Zhai, Chia-Jen Liu, Andi K. Cani, Daniel H. Hovelson, Andrew S. McDaniel
Penile squamous cell carcinoma (PeSCCA) is a rare malignancy for which there are limited treatment options due to a poor understanding of the molecular alterations underlying disease development and progression. Therefore, we performed comprehensive,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd64ba6b17c618f6517d03809753ee83
https://doi.org/10.1158/0008-5472.c.6507210.v1
https://doi.org/10.1158/0008-5472.c.6507210.v1
Autor:
Scott A. Tomlins, Daniel R. Rhodes, Kathleen R. Cho, Paul D. Williams, Santhoshi Bandla, Seth Sadis, Javed Siddiqui, Jeffrey S. Montgomery, Todd M. Morgan, Ajjai S. Alva, Felix Y. Feng, Rohit Mehra, Alon Z. Weizer, Yajia Zhang, Yali Zhai, Chia-Jen Liu, Andi K. Cani, Daniel H. Hovelson, Andrew S. McDaniel
Sanger sequencing validation of next generation sequencing (NGS) variant calls ; Alternative view of integrative molecular profiling heatmap ; p16 expression via immunohistochemistry ; Kaplan-Meier analysis of histologic subtypes of PeSCCA ; Comparis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::091652e55132dc36b0d86e30c9384f34
https://doi.org/10.1158/0008-5472.22406994.v1
https://doi.org/10.1158/0008-5472.22406994.v1
Autor:
Scott A. Tomlins, Daniel R. Rhodes, Kathleen R. Cho, Paul D. Williams, Santhoshi Bandla, Seth Sadis, Javed Siddiqui, Jeffrey S. Montgomery, Todd M. Morgan, Ajjai S. Alva, Felix Y. Feng, Rohit Mehra, Alon Z. Weizer, Yajia Zhang, Yali Zhai, Chia-Jen Liu, Andi K. Cani, Daniel H. Hovelson, Andrew S. McDaniel
Clinicopathologic data for all profiled penile squamous cell carcinoma (PeSCCA) samples ; Sequencing data for all profiled penile squamous cell carcinoma (PeSCCA) samples ; Detailed somatic variant information from PeSCCA profiled by next generation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20bb80bac998cc18ad1fc7f07c0307b4
https://doi.org/10.1158/0008-5472.22406988.v1
https://doi.org/10.1158/0008-5472.22406988.v1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.